Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study.
about
Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study.No differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy.Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.Consolidation of molecular testing in clinical virology.Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.
P2860
Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@ast
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@en
type
label
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@ast
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@en
prefLabel
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@ast
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@en
P2093
P2860
P50
P356
P1476
Inflammatory, procoagulant mar ...... rapy: a cross-sectional study.
@en
P2093
Francisco Xavier Zamora
Juan Julián González-García
Maria Luisa Montes
P2860
P2888
P356
10.1186/1471-2334-14-379
P50
P577
2014-07-10T00:00:00Z
P5875
P6179
1015640296